tiprankstipranks
Regenxbio price target raised to $38 from $34 at Leerink
PremiumThe FlyRegenxbio price target raised to $38 from $34 at Leerink
4d ago
Spirit enters into bankruptcy proceedings, CVS names new directors: Morning Buzz
Premium
The Fly
Spirit enters into bankruptcy proceedings, CVS names new directors: Morning Buzz
4d ago
Regenxbio initiates pivotal phase of Affinity Duchenne trial of RGX-202
Premium
The Fly
Regenxbio initiates pivotal phase of Affinity Duchenne trial of RGX-202
4d ago
Regenxbio sees cash and securities sufficient into 2026
PremiumThe FlyRegenxbio sees cash and securities sufficient into 2026
16d ago
RGNX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
RGNX Upcoming Earnings Report: What to Expect?
18d ago
Regenxbio presents positive Phase 2 data of ABBV-RGX-314 in wet AMD
Premium
The Fly
Regenxbio presents positive Phase 2 data of ABBV-RGX-314 in wet AMD
1M ago
RegenXBio Appoints New EVP and CFO Amidst Key Developments
PremiumCompany AnnouncementsRegenXBio Appoints New EVP and CFO Amidst Key Developments
2M ago
Regenxbio names Mitchell Chan as CFO, succeeding Vit Vasista
Premium
The Fly
Regenxbio names Mitchell Chan as CFO, succeeding Vit Vasista
2M ago
JMP Securities healthcare analysts hold an analyst/industry conference call
Premium
The Fly
JMP Securities healthcare analysts hold an analyst/industry conference call
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100